Fig. 4
From: Baicalein reduces the occurrence of cirrhotic endotoxemia by reducing intestinal mucosal apoptosis
mRNA expression of β-actin, Bcl-2 and Bax in each group. Note: Lanes: 1 marker; 2 normal control group; 3 model group; 4 glutamine group; 5 BA treatment group. a β-actin mRNA expression in each group; length of target product: 241 bp. b Bcl-2 mRNA expression in each group; length of target product: 269 bp. c Bax mRNA expression in each group; length of target product: 272 bp